DavidEThalerMDPhD, FAHA

PubMed

• 9 citations
  Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale Closure.
  Jean-Louis Mas, Jeffrey L Saver, Scott E Kasner, Jason Nelson, John D Carroll, Gilles Chatellier, Geneviève Derumeaux, Anthony J Furlan, Howard C Herrmann, Peter Jüni,...> ;JAMA Neurology. 2022 Nov 1
• Treatment Effects in Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale-Reply.
  David M Kent, Jeffrey L Saver, David E Thaler> ;JAMA. 2022 Apr 12
• 70 citations
  Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.
  David M Kent, Jeffrey L Saver, Scott E Kasner, Jason Nelson, John D Carroll, Gilles Chatellier, Geneviève Derumeaux, Anthony J Furlan, Howard C Herrmann, Peter Jüni, J...> ;JAMA. 2021 Dec 14
• 138 citations
  Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
  Dhanunjaya Lakkireddy, David E. Thaler, Christopher R. Ellis, Vijendra Swarup, Lars Søndergaard, John D. Carroll, Michael R. Gold, James B. Hermiller, Hans-Christoph D...> ;Circulation. 2021 Nov 9
• 2 citations
  Detection of symptoms of late complications after stroke in young survivors with active surveillance versus usual care.
  Sarah Gans, Elena Michaels, David E. Thaler, Lester Y. Leung> ;Disability and Rehabilitation. 2021 Feb 19
• 29 citations
  Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
  David M. Kent, Jeffrey L. Saver, Robin Ruthazer, Anthony J. Furlan, Mark Reisman, John D. Carroll, Richard W. Smalling, Peter Jüni, Heinrich Mattle, Bernhard Meier, Da...> ;Stroke. 2020 Sep 14
• 3 citations
  Differences in presenting symptoms of acute stroke among young and older adults.
  Haley E. Huggins, Merrill Brady, Jost-Price Emma, David E. Thaler, Lester Y. Leung> ;Journal of Stroke and Cerebrovascular Diseases. 2020 Aug 1
• 1 citations
  Prior Stroke in PFO Patients Is Associated With Both PFO-Related and -Unrelated Factors
  Timo Kahles, Patrik Michel, Alexander Hapfelmeier, Franz R. Eberli, Marialuisa Zedde, Vincent Thijs, Markus Kraemer, Stefan T. Engelter, Joaquín Serena, Christian Weim...> ;Frontiers in Neurology. 2020 Jun 4
• Risk Management: “High-Risk” PFOs Come Into Partial Focus
  David E. Thaler> ;Journal of the American College of Cardiology. 2020 May 12
• 91 citations
  Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke.
  Akram Y. Elgendy, Jeffrey L. Saver, Zahid Amin, Konstantinos Dean Boudoulas, John D. Carroll, Islam Y. Elgendy, Iris Q. Grunwald, Zachary M. Gertz, Ziyad M. Hijazi, Er...> ;JAMA Neurology. 2020 Apr 13
• 24 citations
  Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).
  Dhanunjaya Lakkireddy, Stephan Windecker, David E. Thaler, Lars Søndergaard, John D. Carroll, Michael R. Gold, Hongfei Guo, Kyle J. Brunner, James B. Hermiller, Hans-C...> ;American Heart Journal. 2019 May 1
• 3 citations
  Patients’ responses to incidentally discovered silent brain infarcts – a qualitative study
  Lester Y. Leung, Paul K. J. Han, Christine Lundquist, Gene Weinstein, David E. Thaler, David M. Kent> ;Journal of Patient-Reported Outcomes. 2019 Apr 15
• Patent foramen ovale: the known unknowns.
  David E. Thaler, Sarah Gans> ;Eurointervention. 2019 Jan 20
• Response by Saver et al to Letter Regarding Article, "Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review".
  Jeffrey L. Saver, Heinrich Mattle, David E. Thaler> ;Stroke. 2018 Dec 1
• 7 citations
  Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.
  Hans-Christoph Diener, Christian Gerloff, David E. Thaler, Jochen Wöhrle> ;Current Neurology and Neuroscience Reports. 2018 Oct 17
• A priori, a posteriori, and back again: A priori posteriori?
  David E. Thaler, Vasileios-Arsenios Lioutas> ;Neurology. 2018 Jul 3
• 5 citations
  Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack.
  David E. Thaler> ;The Lancet. Neurology. 2018 Jul 1
• 2 citations
  Correction: Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.
  Lester Y. Leung, Paul K. J. Han, Christine Lundquist, Gene Weinstein, David E. Thaler, David M. Kent> ;Plos One. 2018 May 16
• 575 citations
  Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.
  Sharonne N. Hayes, Esther S.H. Kim, Jacqueline Saw, David Adlam, Cynthia Arslanian-Engoren, Katherine E. Economy, Santhi K. Ganesh, Rajiv Gulati, Mark E. Lindsay, Jenn...> ;Circulation. 2018 May 8
• 29 citations
  Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention
  Michelle H. Leppert, Sharon N. Poisson, John D. Carroll, David E. Thaler, Chong H. Kim, Karen D. Orjuela, P. Michael Ho, James F. Burke, Jonathan D. Campbell> ;Stroke. 2018 Jan 1
• 14 citations
  Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention
  David L. Tirschwell, Mark S. Turner, David E. Thaler, James Choulerton, David Marks, John D. Carroll, Lee A. MacDonald, Richard W. Smalling, Maria Koullick, Ning Yan G...> ;Journal of Medical Economics. 2018 Apr 13
• 9 citations
  Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.
  Lester Y. Leung, Paul K. J. Han, Christine Lundquist, Gene Weinstein, David E. Thaler, David M. Kent> ;Plos One. 2018 Mar 29
• 56 citations
  Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.
  Jeffrey L. Saver, Heinrich Mattle, David E. Thaler> ;Stroke. 2018 Jan 1
• 3 citations
  Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.
  Emiliya Melkumova, David E. Thaler> ;Interventional Cardiology Clinics. 2017 Oct 1
• 579 citations
  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
  Jeffrey L. Saver, John D. Carroll, David E. Thaler, Richard W. Smalling, Lee A. MacDonald, David Marks, David L. Tirschwell> ;The New England Journal of Medicine. 2017 Sep 14
• Join now to see all

Journal Articles

• Association of Ischemic Stroke, Hormone Therapy, and Right to Left Shunt in Postmenopausal Women  
  NC, Liebeskind DS, Gevorgyan R, Truong T, Cua B, Tseng C, Dodick DW, Demaerschalk BM, Thaler DE, Tobis JM, Catheterization and Cardiovascular Interventions, 1/1/2014
• Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs  
  Thaler DE, Ruthazer R, Weimar C. et. al., Neurology, 1/1/2014
• Patient Selection for PFO Closure Based on the RoPE Study  
  Thaler DE, Cardiac Interventions Today, 1/1/2014
• Management strategies for asymptomatic carotid stenosis: A systematic review and meta-analysis  
  Raman G, Moorthy D, Hadar N, Dahabreh IJ, O’Donnell TF, Thaler DE, Feldmann E, Lau J, Kitsios GD, Ann Internal Med, 1/1/2013
• Closure of patent foramen ovale versus medical therapy after cryptogenic stroke  
  Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL for the RESPECT Investigators, NEJM, 1/1/2013
• Response to letter regarding article, “Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale: The Hole Truth?”  
  Thaler DE and Wahl A, Stroke, 1/1/2013
• Do We Know, or Do We Believe?  
  Thaler DE and C. Kimmelstiel, Cath Cardiovasc Interv, 1/1/2013
• Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure  
  Korabathina R, Thaler DE, Kimmelstiel, Catheterization and Cardiovascular Interventions, 1/1/2012
• Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis  
  Kitsios GD, Lasker A, Singh J, Thaler DE, Neurology, 1/1/2012
• The Risk of Paradoxical Embolism (RoPE) Study: Initial description of the completed database  
  Thaler DE, Di Angelantonio E, Di Tullio MR, Donovan JS, Elkind MSV, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Rut..., International Journal of Stroke, 1/1/2012
• Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale: The Hole Truth?  
  Thaler DE, Wahl A, Stroke, 1/1/2012
• Bilateral subperiosteal hemorrhage of the orbit  
  Dibner MS, Carmody J, Strominger M, Kapadia M, and Thaler DE, Neurology, 1/1/2012
• The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cry...  
  Kent DM, Thaler DE, Trials, 1/1/2011
• Rethinking trial strategies for stroke and patent foramen ovale  
  Thaler DE, Kent DM, Curr Opinion Neurol, 1/1/2010
• Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic? A Systematic Review and Bayesian Approach  
  Alsheikh-Ali AA, Thaler DE, Kent DM, Stroke, 1/1/2009
• Patent foramen ovale and MRI: can imaging the brain tell us about the heart?  
  Thaler DE and DM Kent, Eur J Neurol, 1/1/2009
• Patent foramen ovale and cryptogenic stroke (letter to the editor)  
  Kent DM, Thaler DE, Trikalinos, NEJM, 1/1/2008
• Cryptogenic stroke and patent foramen ovale  
  Thaler DE, Saver JL, Curr Opinion Cardiol, 1/1/2008
• Stroke prevention – Insights from incoherence  
  Kent DM and Thaler DE, NEJM, 1/1/2008
• Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study  
  Kimmelstiel C, Gange C, Thaler D, Catheter Cardiovasc Interv, 1/1/2007
• A Review of Stroke DRG Mortality Rate as a Quality of Care Measure  
  Hwang SW, Salem D, Thaler D, Heilman CB, AAANS Bulletin, 1/1/2007
• Data that may shed some light on: “arguments insisting on randomized trials for PFO closure  
  Carrol J, Onorato E, Saver J, Smalling R, Thaler D, Tobis J, Catheter Cardiovasc Interv, 1/1/2007
• Coma, Evoked Potentials, Blood Tests, and Crystal Balls  
  Thaler DE, Journal Watch: Neurology, 1/1/2006
• Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke  
  Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A, Stroke, 1/1/2004
• Risk factors for untreated hypertension in hemorrhagic stroke  
  Thaler DE, Journal Watch: Neurology, 1/1/2004
• Join now to see all

Books/Book Chapters

• Imaging Cerebrovascular Disease 
  Chapter: Cerebral infarction during its subacute stage 
  Thaler DE, Sloan MA, Babikian VLEditors: Babikian VL, Wechsler LR, Higashida RT.Butterworth-Heinemann, Philadelphia, PA2003
• Oxford Handbook of Clinical Medicine: American Edition 
  Thaler D, Longmore M, and Hope ROxford University Press1999

Abstracts/Posters

• Anticoagulation versus Antiplatelet Therapy in Patients with Cryptogenic Stroke and Patent Foramen Ovale: An Adjusted Individual Patient Data and RoPE Score-Stratified...
  Kent DM, Dahabreh IJ, Ruthazer R, Furlan A, Weimar C, Serena J, Meier B, Mattle HP, Di Angelantonio E, Paciaroni M, Schuchlenz H, Homma S, Jaigobin C, Lutz JS, Thaler DE, European Stroke Conference, Nice, France, 1/1/2014
• Predictors Differ in Patients With ‘Probable Pathogenic’ Versus Other PFOs
  Thaler DE, Ruthazer R, Angelantonio ED, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattel HP, Michel P, Mono ML, Nedeltchev K, Papet..., International Stroke Conference, Honolulu, HI, 1/1/2013
• An Analysis of ‘High Risk’ Features on Transesophageal Echocardiography in the Risk of Paradoxical Embolism Database
  Wessler B, Thaler DE, Di Tullio MR, Ruthazer R, Weimar C, Mas JL, Serena J, Angelantonio ED, Donovan JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono M..., International Stroke Conference, Honolulu, HI, 1/1/2013
• Late Adverse Events of Patent Foramen Ovale Closure: A Systematic Review
  Nelson S, Green A, Rhodes J, Thaler DE, International Stroke Conference, Honolulu, HI, 1/1/2013
• Cryptogenic Stroke and Patent Foramen Ovale: Posterior Circulation Strokes Are More Common In Men Than In Women
  Thaler DE, Ruthazer R, Angelantonio ED, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papet..., International Stroke Conference, Honolulu, HI, 1/1/2013
• Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect
  Saver JL, Thaler D, Smalling R, Carroll JD, Berry S, MacDonald L, Marks D, Tirschwell D, Book D, Goldstein L, International Stroke Conference, Honolulu, HI, 1/1/2013
• Late Adverse Events of Patent Foramen Ovale Closure: A Systematic Review
  Nelson S, Green A, Rhodes J, Thaler DE, Annual Meeting of the American Academy of Neurology, San Diego, CA, 1/1/2013
• Further Analysis of Confirmed Endpoint Recurrent Strokes in Patent Foramen Ovale Patients in the RESPECT Trial
  Thaler DE, JL Saver, Smalling R, Carroll JD, EuroPCR Annual Meeting, Paris, France, 1/1/2013
• Superficial and Large Infarcts on Neuroimaging in Patients with Cryptogenic Stroke are Associated with the Presence or Absence of Patent Foramen Ovale
  Thaler DE, Ruthazer R, Weimar C, Serena J, Mas J-L, Homma S, Michel P, Elkind MS, Nedeltchev K, Mono M-L, Mattle H, DiTullio M, Kent DM, Stroke, International Stroke Conference, New Orleans, LA, 1/1/2012
• An Index to Identify Cryptogenic Stroke Patients whose Stroke is likely Attributable to Patent Foramen Ovale
  Kent DM; Ruthazer R, Weimar C, Serena J, Mas J-L; Homma S, Michel P, Elkind MS, Nedeltchev K, Mono M-L, Mattle H, DiTullio M, Thaler DE, International Stroke Conference, New Orleans, LA, 1/1/2012
• Hormone Replacement Therapy and Right-to-Left Intracardiac Shunts are More Prevalent in Post-menopausal Women with Cryptogenic Stroke
  Truong T, Gevorgyan R, Greep N, Tseng C-H, Liebeskind D, Demaerschalk B, Dodick D, Thaler DE, Tobis J, JACC, American College of Cardiology’s Scientific Sessions, Chicago, IL, 1/1/2012
• Warfarin use in patients with cryptogenic stroke and patent foramen ovale is guided by radiological and echocardiographic features and not by conventional vascular ris...
  Thaler DE, Di Tullio MR, Elkind MSV, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Ruthazer R, Serena J, Weimar C, Kent DM, European Stroke Conference, Lisbon, 1/1/2012
• Dissection in the Veterans Administration (DIVA): Re-examining spinal manipulation and cervical artery dissection
  Thaler DE, Cai X, Razmara A, Paulus JK, Switkoski K, Goryachev SD, D’Avolio L, Fariborz PJ, Feldmann E, Annals of Neurology, Annual Meeting of the American Neurological Association, Boston, MA, 1/1/2012
• Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment Trial
  Thaler DE, Carroll J, Saver JL; Smalling R, Van Dorn B, International Stroke Conference, Los Angeles, CA, 1/1/2011
• Stroke Study Using Evoked Potentials (SSEP): Feasibility and Proof of Principle
  Kornbluth JA, Feldmann E, Bergethon P, Alhumayyd Z, Clervil P, Clark-Coller M, Thaler DE, American Academy of Neurology Annual Meeting, Honolulu, HI, 1/1/2011
• Factors Supportive of a Diagnosis of Paradoxical Embolism in Patients with Cryptogenic Stroke and Patent Foramen Ovale Are Not Associated with Radiological Markers of ...
  Kitsios GD , Singh J, Lasker A, Thaler DE, American Academy of Neurology Annual Meeting, Honolulu, HI, 1/1/2011
• Radiological Findings in Patients with Cryptogenic Stroke and Patent Foramen Ovale
  Thaler DE, Lasker A, Singh J, Kitsios GD, American Academy of Neurology Annual Meeting, Honolulu, HI, 1/1/2011
• The Risk of Paradoxical Embolism (RoPE) Study: Initial description of the complete database
  Thaler DE, Kent DK for the RoPE Investigators, European Stroke Conference, Hamburg, Germany, 1/1/2011
• Antiplatelet vs Anticoagulant Therapy Recommended as Best Medical Care in the Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current St...
  Tirschwell DL, Book DS, Carroll JD, Lutsep HL, Pettigrew LC, Saver JL, Smalling RW, Thaler DE, Van Dorn BM, Goldstein LB, and The RESPECT Trial Investigators, International Stroke Conference, San Antonio, TX, 1/1/2010
• Risk Profile of Subjects Enrolled in the Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) Tr...
  Thaler DE, Book DS, Carroll JD, Goldstein LB, Lutsep HL, Saver JL, Smalling RW, Tirschwell DL, Van Dorn BM, and the RESPECT Trial Investigators, American Academy of Neurology Annual Meeting, Toronto, 1/1/2010
• The definition of cryptogenic stroke and the investigations needed to diagnose it are not consistent across studies
  Bonow RH, Thaler DE, Kent DM, European Stroke Conference, Barcelona, Spain, 1/1/2010
• Randomized evaluation of recurrent stroke comparing PFO closure to established current standard of care treatment (RESPECT) trial
  Thaler DE, Saver JL, Carroll JD, Smalling RW, Lyle CT, Veltum-Dockter K, International Stroke Conference, San Francisco, CA, 1/1/2007
• Reduction in Migraine Symptoms Following PFO Closure: A Controlled Study
  Kimmelstiel CD, Gange C, Lyle C, Thaler DE, Stroke, 31st International Stroke Conference, Kissimmee, FL, 1/1/2006
• The clinical features of retinal ischemia in the Tufts-New England Medical Center patent foramen ovale (PFO) Database
  Thaler DE, Neurology, 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, 1/1/2006
• Thaler DE, O’Toole M, 28th International Stroke Conference, Phoenix, AZ, 1/1/2003
• Join now to see all

Lectures

• Practical Management of PFOs 
  Harvard Medical School, Dept of Continuing Education, Boston, MA, 2013, 2014 - 1/1/2014
• Patent Foramen Ovale and Stroke: Finally some evidence 
  Tufts Medical Center, Boston, MA - 1/1/2014
• How to identify the patient with PFO stroke 
  La Jolla, CA - 1/1/2014
• PFO and Stroke: Finally Some Data 
  1/1/2014
• Spinal Manipulation therapy and arterial dissection 
  Boston, MA - 1/1/2014
• PFO and Stroke: Let me show you the RoPE 
  Massachusetts General Hospital Stroke Service, Boston, MA - 1/1/2014
• PFOs should be closed in patients with cryptogenic stroke 
  Copenhagen, Denmark - 1/1/2014
• Patent Foramen Ovale and Stroke: Finally some data 
  Multiple locations, 2013 - 1/1/2013
• The PFO: News from Trials and RESPECT: A deep dive into the data 
  Milan, Italy - 1/1/2013
• Update on PFO, Trials and tribulations 
  San Francisco, CA - 1/1/2013
• Closing PFOs for Strokes … Finally we have some data?!? 
  New Paultz, NY - 1/1/2013
• Patent Foramen Ovale and Stroke, Finally some data 
  Beth Israel Deaconess Medical Center, Needham, MA - 1/1/2013
• How to attribute a stroke to a PFO: facts and models 
  Zurich, Switzerland - 1/1/2013
• PFO closure would benefit from a CHADS-Like score to select the patients who will benefit 
  San Francisco, CA - 1/1/2013
• Vertebral Dissection following Chiropractic Manipulation - What is the Risk? 
  Boston Medical Center (Boston University), Boston, MA - 1/1/2012
• Patent Foramen Ovale: Epidemiology, Evidence, and Trial Design 
  Lawrence Memorial Hospital, Medford, MA, 2012 ; Melrose-Wakefield, Medford, MA, 2012 - 1/1/2012
• Risk of Paradoxical Embolism (RoPE) Study 
  Frankfurt, Germany - 1/1/2012
• Cryptogenic stroke vs PFO Stroke? Neurology perspectives, Late breaking clinical trials – RESPECT, PC Trial 
  Miami, FL - 1/1/2012
• The Case of Ms LL: Spinal manipulation therapy and vertebral artery dissection 
  Yale-New Haven Hospital, New Haven, CT - 1/1/2012
• Neurological Complications of Chiropractic 
  Saints Medical Center, Lowell, MA - 1/1/2011
• A Practical Approach to PFO 
  Boston, MA - 1/1/2011
• PFO, Stroke and Migraine 
  Lowell General Hospital, Lowell, MA - 1/1/2011
• Overview of PFO/Stroke Studies, PFO Propensity and Recurrence Risk and How Does a Neurologist Determine that a PFO Caused a Stroke? 
  Boston, MA - 1/1/2011
• PFO and Stroke: Case Closed 
  Yale University, New Haven, CT - 1/1/2011
• PFO Closure for Stroke Prevention: Meta-Analysis Evidence from Non-Randomized Trials 
  San Francisco, CA - 1/1/2011
• Join now to see all

Other

• Supplementary Motor Cortex and the Control of Action 
  Thaler D
  1/1/1988
• Differing Predictors for Recurrent Stroke Among Treated Patients With Possible Incidental PFO 
  Thaler DE, PracticeUpdate website
  http://www.practiceupdate.com/journalscan/11250
  1/12/2014